Cellink AB (publ)
BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Life Science Solutions, and Lab Automation. The Bioprinting segment offers 3D bioprinters and bioinks with a range of technologies for various applications, resolutions, and volume/speed requirements, as well as… Read more
Market Cap & Net Worth: Cellink AB (publ) (CLLKF)
Cellink AB (publ) (PINK:CLLKF) has a market capitalization of $210.68 Million ($210.68 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #16666 globally and #6397 in its home market, demonstrating a -16.44% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Cellink AB (publ)'s stock price $3.05 by its total outstanding shares 69074895 (69.07 Million).
Cellink AB (publ) Market Cap History: 2020 to 2025
Cellink AB (publ)'s market capitalization history from 2020 to 2025. Data shows change from $1.97 Billion to $210.68 Million (-21.07% CAGR).
Cellink AB (publ) Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Cellink AB (publ)'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.14x
Cellink AB (publ)'s market cap is 0.14 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $1.97 Billion | $176.79 Million | -$61.89 Million | 11.14x | N/A |
| 2021 | $2.05 Billion | $1.26 Billion | -$227.60 Million | 1.63x | N/A |
| 2022 | $701.11 Million | $2.24 Billion | -$832.90 Million | 0.31x | N/A |
| 2023 | $427.57 Million | $2.01 Billion | -$1.17 Billion | 0.21x | N/A |
| 2024 | $207.92 Million | $1.95 Billion | -$5.50 Million | 0.11x | N/A |
| 2025 | $210.68 Million | $1.49 Billion | -$1.09 Billion | 0.14x | N/A |
Competitor Companies of CLLKF by Market Capitalization
Companies near Cellink AB (publ) in the global market cap rankings as of March 18, 2026.
Key companies related to Cellink AB (publ) by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
Cellink AB (publ) Historical Marketcap From 2020 to 2025
Between 2020 and today, Cellink AB (publ)'s market cap moved from $1.97 Billion to $ 210.68 Million, with a yearly change of -21.07%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $210.68 Million | +1.33% |
| 2024 | $207.92 Million | -51.37% |
| 2023 | $427.57 Million | -39.01% |
| 2022 | $701.11 Million | -65.81% |
| 2021 | $2.05 Billion | +4.18% |
| 2020 | $1.97 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Cellink AB (publ) was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $210.68 Million USD |
| MoneyControl | $210.68 Million USD |
| MarketWatch | $210.68 Million USD |
| marketcap.company | $210.68 Million USD |
| Reuters | $210.68 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.